Wellington Shields Capital Management’s Precigen PGEN Stock Holding History

Wellington Shields Capital Management’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-20,000	Closed	-$68K	–	245
2020 Q1	$68K	Hold	20,000	–	–	0.01%	227
2019 Q4	$110K	Sell	20,000 -220,800	-92%	-$1.24M	0.02%	258
2019 Q3	$1.38M	Buy	240,800 +4,000	+2%	+$27.2K	0.22%	92
2019 Q2	$1.81M	Sell	236,800 -5,000	-2%	-$26.9K	0.3%	75
2019 Q1	$1.27M	Buy	241,800 +83,000	+52%	+$575K	0.22%	96
2018 Q4	$1.04M	Sell	158,800 -59,000	-27%	-$661K	0.2%	109
2018 Q3	$3.75M	Hold	217,800	–	–	0.61%	32
2018 Q2	$3.04M	Sell	217,800 -10,000	-4%	-$169K	0.5%	39
2018 Q1	$3.49M	Buy	+227,800	New	+$3.26M	0.53%	34

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Wellington Shields Capital Management's PGEN Position: Q2 2020 in Review

Wellington Shields Capital Management sold out of Precigen (PGEN) in Q2 2020, closing a stake of 20,000 shares — an estimated $68K sold.

Wellington Shields Capital Management first reported a position in PGEN in Q1 2018 and held it in 9 quarters. The position peaked at $3.75M in Q3 2018. 154 funds tracked by Wall St. Rank hold PGEN as of Q2 2020.

Wellington Shields Capital Management reported no remaining Precigen position as of Q2 2020 after selling out during the quarter.
Wellington Shields Capital Management sold 20,000 Precigen shares in Q2 2020, an estimated $68K.
Wellington Shields Capital Management first reported a position in Precigen in Q1 2018 and held it in 9 quarters.
Wellington Shields Capital Management's Precigen position peaked at $3.75M in Q3 2018.
154 funds tracked by Wall St. Rank held Precigen as of Q2 2020.

Based on Wellington Shields Capital Management's 13F filing for Q2 2020, filed 5 Aug 2020.